Search
35 result(s) for 'author#Paolo Calabresi' within BMC
Page 1 of 2
Sort by: Relevance | Date
-
Citation: The Journal of Headache and Pain 2017 18(Suppl 1):111
-
12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches
Citation: The Journal of Headache and Pain 2018 19(Suppl 1):80 -
ORAL COMMUNICATIONS WITH POSTERS
Citation: The Journal of Headache and Pain 2006 7:314 -
ORAL PRESENTATIONS
Citation: The Journal of Headache and Pain 2006 7:313 -
Biological substrates of migraine
Citation: The Journal of Headache and Pain 2015 16(Suppl 1):A19 -
Medication–overuse headache: pathophysiological insights
Medication overuse headache (MOH) is a clinically important entity and it is now well documented that the regular use of acute symptomatic medication by people with migraine or tensiontype headache increases t...
Citation: The Journal of Headache and Pain 2005 6:184 -
Oral Communications
Citation: The Journal of Headache and Pain 2005 6:229 -
Migraine and epilepsy: what value today?
Citation: The Journal of Headache and Pain 2015 16(Suppl 1):A44 -
Correction to: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
Following publication of the original article [1], the authors reported an error in the affiliation of the third author, Sara Gandini. The correct affiliation should read: Division of Epidemiology and Biostati...
Citation: Nutrition Journal 2019 18:54 -
Current and emerging evidence-based treatment options in chronic migraine: a narrative review
Chronic migraine is a disabling condition that is currently underdiagnosed and undertreated. In this narrative review, we discuss the future of chronic migraine management in relation to recent progress in evi...
Citation: The Journal of Headache and Pain 2019 20:92 -
P066. Migraine with aura in the locker room: 4 case reports
Citation: The Journal of Headache and Pain 2015 16(Suppl 1):A169 -
Application of ICHD 2nd edition criteria for primary headaches with the aid of a computerised, structured medical record for the specialist
We tested the computerised, structured medical record by entering and analysing the consecutive clinical sheets of primary headaches in the episodic forms (200) and chronic headache (200) and the corresponding...
Citation: The Journal of Headache and Pain 2005 6:186 -
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
Lysosomal dysfunction is thought to be a prominent feature in the pathogenetic events leading to Parkinson’s disease (PD). This view is supported by the evidence that mutations in GBA gene, coding the lysosomal h...
Citation: Molecular Neurodegeneration 2015 10:15 -
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein
Neuroacanthocytosis (NA) denotes a heterogeneous group of diseases that are characterized by nervous system abnormalities in association with acanthocytosis in the patients' blood. The 4.1R protein of the eryt...
Citation: BMC Neurology 2007 7:4 -
Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache
Medication overuse headache (MOH) is a very heterogeneous disorder for which a recommended treatment is not yet available. The purpose of this study was to investigate any possible roles of demographic and cli...
Citation: The Journal of Headache and Pain 2014 15:88 -
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB
The introduction of monoclonal antibodies (mAbs) against calcitonin-gene related peptide (CGRP) or CGRP receptors in the treatment of migraine raised concerns on the possible risks associated to the long-term ...
Citation: The Journal of Headache and Pain 2020 21:124 -
2nd European Headache and Migraine Trust International Congress-EHMTIC
Citation: The Journal of Headache and Pain 2010 11(Suppl 1):259 -
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?
Citation: The Journal of Headache and Pain 2015 16(Suppl 1):A69 -
Migraine-specific quality of life questionnaire and relapse of medication overuse headache
The management of Medication overuse headache (MOH) represents a difficult challenge for clinicians and headache experts, particularly for the responder rate after a successful withdrawal treatment. The purpos...
Citation: BMC Neurology 2015 15:85 -
CACNA1A-p.Thr501Met mutation associated with familial hemiplegic migraine: a family report
Hemiplegic migraine (HM) is a rare form of migraine characterized by the presence of a motor and other types of aura. HM can be sporadic or familial. Familial hemiplegic migraine (FHM) is an autosomal dominant...
Citation: The Journal of Headache and Pain 2021 22:85